GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer

$362,252
Stephen J Pandol · Cedars-Sinai Medical Center · U01 · FY2023 · DK

Networks for functional regulation of pancreatic acinar-ductal metaplasia and epithelial plasticity

$362,250
Anil K Rustgi · University Of Pennsylvania · R01 · FY2016 · DK

Networks for functional regulation of pancreatic acinar-ductal metaplasia and epithelial plasticity

$362,250
Anil K Rustgi · University Of Pennsylvania · R01 · FY2017 · DK

Networks for functional regulation of pancreatic acinar-ductal metaplasia and epithelial plasticity

$362,250
Anil K Rustgi · University Of Pennsylvania · R01 · FY2018 · DK

Advancing the Clinical Translation of Cyst Fluid Assays for Early Detection of Pancreatic Cancer

$362,177
Kimberly Saunders Kirkwood · University Of California, San Francisco · U01 · FY2025 · CA

MODULATING NEURAL SIGNALING IN THE TREATMENT OF PANCREATIC CANCER

$362,124
The Trustees Of Columbia University In The City Of New York · · FY2021 · Defense Health Agency

Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO

$362,123
Rachael Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA

Bispecific T cell engagers for the treatment of pancreatic ductal adenocarcinoma

$362,118
Nathan G. Dolloff · Leukogene Therapeutics, Inc. · R41 · FY2021 · CA

Integrated Genomic-Transcriptomic Characterization to Identify Molecular Mechanisms of Disparities in PDAC Outcomes

$362,050
Vikas Dudeja · University Of Alabama At Birmingham · R21 · FY2024 · CA

Dissecting new mechanisms of lysosome quality control in health and disease

$362,043
Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2023 · CA

Identifying Molecular Drivers of Cellular Plasticity in Pancreatic Cancer

$362,043
Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2022 · CA

Dissecting new mechanisms of lysosome quality control in health and disease

$362,043
Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2022 · CA

Identifying Molecular Drivers of Cellular Plasticity in Pancreatic Cancer

$362,043
Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2023 · CA

Dietary Regulation of Pancreatic Digestive Enzymes

$361,906
John A Williams · University Of Michigan At Ann Arbor · R01 · FY2009 · DK

Mechanisms of PAK1 activation, signaling and tumor resistance

$361,887
Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA

Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy

$361,779
Weiqin Lu · State University New York Stony Brook · R01 · FY2021 · CA

Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy

$361,779
Weiqin Lu · State University New York Stony Brook · R01 · FY2020 · CA

Accessible high-throughput single-cell genome sequencing

$361,588
Andrew Adey · Oregon Health & Science University · R33 · FY2024 · CA

Targeting aberrant circadian regulator in advanced prostate cancer

$361,521
Hongwu Chen · University Of California At Davis · R01 · FY2022 · CA

Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer

$361,444
James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer

$361,441
Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG

Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells

$361,438
Yingxiao Wang · University Of California, San Diego · R33 · FY2018 · CA

Functional Characterization of CCDC130 Gene

$361,350
Deepak Kumar · University Of The District Of Columbia · SC1 · FY2012 · CA

Functional Characterization of CCDC130 Gene

$361,350
Deepak Kumar · University Of The District Of Columbia · SC1 · FY2011 · CA

Synergistic chemo-siRNA combination therapy

$361,309
M Guillaume Wientjes · Optimum Therapeutics, Llc · R01 · FY2014 · CA